This conference will benefit venture capitalists and angel investors who are interested in early-stage life sciences companies. Key attendees will be business development and senior executives from biotech, pharmaceutical and biomedical companies.
Be among the first to see a range of new companies spun off from Massachusetts research institutions, and see new technologies that are available for commercialization through licensing agreements and the creation of new companies.
Yes, we will consider you as a presenter, but you must apply. Click here to apply online.
Featuring Life Sciences Companies and Technologies from Research Institutions in Massachusetts
April 28, 2005
Noon - 6 P.M.
The Conference Center at Harvard Medical
77 Avenue Louis Pasteur
Boston, Massachusetts
The Early-Stage Life Sciences Technology Conference is a showcase for platform technologies and recently formed companies that are based on research developed at Massachusetts research institutions, hospitals and universities. Presenters will include founders of new companies spun off from Massachusetts institutions and faculty with technologies that could be the basis of a start-up or license. This is an opportunity for angel investors, venture capitalists and corporate investors to see some of the newest life sciences companies in the Commonwealth.
Would you like to be a presenter? Please click here to apply online.
Keynote panel discussion:
A group of senior business development executives from large
pharmaceutical companies will discuss their corporate technology needs,
their reasons for locating in Massachusetts and their interactions with
research institutions.
Formal company presentations:
There will be formal presentations by a select group of early-stage
spin-off companies and faculty seeking their first round of
professional investment.
Reception and poster session: A networking reception will include poster presentations by all of the presenting companies and by additional institutions and incubating companies.
>> Back to top
Noon Lunch
1:00 Panel discussion with leading executives from "Big Pharma" Why have these companies located in Massachusetts? What technologies are they most interested in? What types of partnership deals do they typically make with early-stage companies?
PANELISTS:
Fran Heller
Head of Strategic Alliances
Novartis Pharmaceuticals
Dr. Robert Gould
Vice President, Licensing and External Research
Merck Research Labs
Dr. Maggie Flanagan
Global Alliance Director for Global Sciences and Information
AstraZeneca PharmaceuticalsMike Clark
Strategic Alliances Director
Pfizer Research Technology Center
2:00 Company presentations (12 minutes per company)
4:30 Networking reception and poster session
Registration: >> Click here to register>> Back to top
$5,000 Sponsorships Available
Sponsorship benefits:For sponsorship information, please contact:
Abigail Barrow
(617) 287-7071
abarrow@umassp.edu
>> Back to top
Conference Sponsors |
 |
 |
 |
 |
